http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102203675-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R1-91
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11D3-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-34635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L3-3571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C11D3-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-195
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D3-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L3-3571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L3-3463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11D3-48
filingDate 2019-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102203675-B1
titleOfInvention Novel Yersinia specific bacteriophage YE12 and antibacterial composition comprising the same
abstract The present invention relates to a novel Yersinia bacteria-specific bacteriophage YE12, and more particularly, to an antibacterial composition comprising the Yersinia bacteria-specific bacteriophage YE12. The bacteriophage YE12 according to the present invention has a very high specificity for Yersinia bacteria, has excellent lytic activity by infecting Yersinia bacteria and proliferates in Yersinia bacteria, and has the advantage of being strong against physicochemical stimulation. In addition, since the bacteriophage YE12 of the present invention does not infect other hosts other than bacteria such as humans, animals, plants, etc., it can solve the problems of antibiotic-resistant bacteria due to the misuse of antibiotics, the problem of remaining antibiotics in food, and the problems of a wide host range. It can be used in a variety of fields for composition, composition for feed addition, feed, disinfectant or cleaning agent.
priorityDate 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453366338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218629

Total number of triples: 35.